STRS Ohio’s Aligos Therapeutics ALGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-100
Closed -$69K 2170
2020
Q4
$69K Buy
+100
New +$48.7K ﹤0.01% 1955

Other funds holding ALGS

STRS Ohio's ALGS Position: Q1 2021 in Review

STRS Ohio sold out of Aligos Therapeutics (ALGS) in Q1 2021, closing a stake of 100 shares — an estimated $69K sold.

STRS Ohio first reported a position in ALGS in Q4 2020 and held it in 1 quarter. The position peaked at $69K in Q4 2020. 52 funds tracked by Wall St. Rank hold ALGS as of Q1 2021.

  • STRS Ohio reported no remaining Aligos Therapeutics position as of Q1 2021 after selling out during the quarter.
  • STRS Ohio sold 100 Aligos Therapeutics shares in Q1 2021, an estimated $69K.
  • STRS Ohio first reported a position in Aligos Therapeutics in Q4 2020 and held it in 1 quarter.
  • STRS Ohio's Aligos Therapeutics position peaked at $69K in Q4 2020.
  • 52 funds tracked by Wall St. Rank held Aligos Therapeutics as of Q1 2021.

Based on STRS Ohio's 13F filing for Q1 2021, filed 23 Apr 2021.